Jason works with clients in the biotechnology and pharmaceutical industries on a wide range of intellectual property issues, including patent portfolio development and life-cycle management, patent prosecution, and freedom-to-operate. He helps clients create and carry out global patent strategies incorporating analysis of the existing patent landscape. Using his experience assessing patents and prosecuting patent application in the United States in many foreign countries, Jason works with clients to develop and execute effective patent strategies focused on obtaining robust and enforceable patent protection around the world.

Jason’s practice also includes performing analyses for advising clients in connection with transactions, such as mergers and acquisitions, licenses, and venture financings. He helps clients evaluate the intellectual property portfolios of target companies and conducts worldwide due diligence assessments. Jason has conducted numerous assessments related to patentability, validity, non-infringement, freedom-to-operate.

Prior to joining the firm, Jason obtained his Ph.D. in Molecular Microbiology and Microbial Pathogenesis from Washington University in St. Louis. While there, he identified novel virulence-associated genes in Yersinia pestis, the causative agent of bubonic and pneumonic plague (“Black Death”), and helped elucidate novel mechanisms of plague pathogenesis in both mammalian and insect hosts in the laboratory of Professor Virginia Miller.